All In Biotech

Free tool

FAERS Monitor: Tnkase

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming BLA 103909 or its brand name (Tnkase, Tenecteplase). Reports on generic versions are filed under their own applications.

Reports

1,600

Serious

1,196

75% of reports

Hospitalization

437

Death reported

375

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • off label use412
  • no adverse event316
  • cerebral haemorrhage162
  • angioedema129
  • haemorrhage intracranial118
  • death81
  • haemorrhage81
  • drug ineffective72
  • cerebrovascular accident71
  • haemorrhagic transformation stroke61
  • subarachnoid haemorrhage47
  • medication error40
  • hypotension39
  • cardiogenic shock34
  • cardiac arrest33

Reports by year received

View as table
YearReports
200425
200531
200612
200725
200815
200937
201014
201132
201255
201356
201428
201518
201616
201778
201848
201944
202055
202174
2022101
2023168
2024345
2025177
2026146

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,052,559 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
haemorrhagic transformation strokeSignal61555.1431.731,844
haemorrhage intracranialSignal118104.687.811,915
subarachnoid haemorrhageSignal4760.945.92,699
cerebral haemorrhageSignal16259.851.69,274
angioedemaSignal12938.432.64,664
cardiogenic shockSignal3431.222.4963
no adverse eventSignal31623.020.86,663
haemorrhageSignal8110.28.2665
medication errorSignal409.57.0295
off label useSignal4126.25.71,863
cerebrovascular accidentSignal715.54.4260
cardiac arrestSignal335.33.7110
hypotensionSignal392.61.936
death811.21.04
drug ineffective720.70.68

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.